{"_buckets": {"deposit": "ab9a1b46-f020-4779-9f77-89b8b48bd853"}, "_deposit": {"created_by": 17, "id": "2002098", "owner": "17", "owners": [17], "owners_ext": {"displayname": "\u56f3\u66f8\u60c5\u5831\u4fc2", "username": "repository"}, "pid": {"revision_id": 0, "type": "depid", "value": "2002098"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:02002098"}, "author_link": [], "item_1615768549627": {"attribute_name": "\u51fa\u7248\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_1629683748249": {"attribute_name": "\u65e5\u4ed8", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2022-08-01", "subitem_date_issued_type": "Available"}]}, "item_9_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "644", "bibliographicPageStart": "639", "bibliographicVolumeNumber": "148", "bibliographic_titles": [{"bibliographic_title": "Journal of Allergy and Clinical Immunology", "bibliographic_titleLang": "en"}]}]}, "item_9_description_4": {"attribute_name": "\u5185\u5bb9\u8a18\u8ff0", "attribute_value_mlt": [{"subitem_description": "Background: Type I interferonopathies are a recently established subgroup of autoinflammatory diseases caused by mutations in genes associated with proteasome degradation or cytoplasmic RNA- and DNA-sensing pathways. Objective: This study aimed to unveil the molecular pathogenesis of a patient with novel type I interferonopathy, for which no known genetic mutations have been identified. Methods: We performed the whole-exome sequencing of a 1-month-old boy with novel type I interferonopathy. We also investigated proteasome activities using patient-derived B lymphoblastoid cell lines (LCLs) and normal LCLs transduced with the mutant gene. Results: Whole-exome sequencing identified a de novo proteasome 20S subunit beta 9 (PSMB9) p.G156D mutation in the patient who developed fever, a chilblain-like skin rash, myositis, and severe pulmonary hypertension due to the hyperactivation of IFN-\u03b1. Patient-derived LCLs revealed reduced proteasome activities, and exogenous transduction of mutant PSMB9 p.G156D into normal LCLs significantly suppressed proteasome activities, and the endogenous PSMB9 protein was lost along with the reduction of other immunoproteasome subunits, PSMB8 and PSMB10 proteins. He responded to the administration of a Janus kinase inhibitor, tofacitinib, and he was successfully withdrawn from venoarterial extracorporeal membranous oxygenation. At age 7 months, he received an unrelated cord blood transplantation. At 2 years posttransplantation, he no longer required tofacitinib and experienced no disease recurrence. Conclusions: We present the case of a patient with a novel type I interferonopathy caused by a de novo PSMB9 p.G156D mutation that suppressed the wild-type PSMB9 protein expression. Janus kinase inhibitor and stem cell transplantation could be curative therapies in patients with severe interferonopathies.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_9_publisher_32": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "Elsevier", "subitem_publisher_language": "en"}]}, "item_9_relation_43": {"attribute_name": "\u95a2\u9023\u60c5\u5831", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1016/j.jaci.2021.03.010", "subitem_relation_type_select": "DOI"}}]}, "item_9_rights_12": {"attribute_name": "\u6a29\u5229", "attribute_value_mlt": [{"subitem_rights": "\u00a9 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/", "subitem_rights_language": "en"}]}, "item_9_source_id_7": {"attribute_name": "\u53ce\u9332\u7269\u8b58\u5225\u5b50", "attribute_value_mlt": [{"subitem_source_identifier": "0091-6749", "subitem_source_identifier_type": "PISSN"}]}, "item_access_right": {"attribute_name": "\u30a2\u30af\u30bb\u30b9\u6a29", "attribute_value_mlt": [{"subitem_access_right": "embargoed access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_f1cf"}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kataoka, Shinsuke", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kawashima, Nozomu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Okuno, Yusuke", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Muramatsu, Hideki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Miwata, Shunsuke", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Narita, Kotaro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Hamada, Motoharu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Murakami, Norihiro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Taniguchi, Rieko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ichikawa, Daisuke", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kitazawa, Hironobu", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Suzuki, Kyogo", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nishikawa, Eri", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Narita, Atsushi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nishio, Nobuhiro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Hidenori", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Fukasawa, Yoshie", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kato, Taichi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Hiroyuki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Natsume, Jun", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Kojima, Seiji", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Nishino, Ichizo", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Taketani, Takeshi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Ohnishi, Hidenori", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Takahashi, Yoshiyuki", "creatorNameLang": "en"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-08-01"}], "displaytype": "detail", "download_preview_message": "Download / Preview is available from 2022/7/31.", "file_order": 0, "filename": "CM_FinalFile_PSMB9_manuscript.pdf", "filesize": [{"value": "1.8 MB"}], "format": "application/pdf", "future_date_message": "Download is available from 2022/7/31.", "is_thumbnail": false, "mimetype": "application/pdf", "size": 1800000.0, "url": {"objectType": "fulltext", "url": "https://nagoya.repo.nii.ac.jp/record/2002098/files/CM_FinalFile_PSMB9_manuscript.pdf"}, "version_id": "c34c6c6e-c951-451e-b033-528fc9ad9dfa"}]}, "item_keyword": {"attribute_name": "\u30ad\u30fc\u30ef\u30fc\u30c9", "attribute_value_mlt": [{"subitem_subject": "JAK inhibitor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "interferonopathy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "pulmonary hypertension", "subitem_subject_scheme": "Other"}, {"subitem_subject": "proteasome subunit beta type 9 (PSMB9)", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor", "subitem_title_language": "en"}]}, "item_type_id": "40001", "owner": "17", "path": ["499/500/501"], "permalink_uri": "http://hdl.handle.net/2237/0002002098", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2022-02-14"}, "publish_date": "2022-02-14", "publish_status": "0", "recid": "2002098", "relation": {}, "relation_version_is_last": true, "title": ["Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor"], "weko_shared_id": -1}